Rezultati - Silvia Bader‐Weder

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy

    An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy od Jennifer M. Kwon, Kapil Arya, Nancy L. Kuntz, Han C. Phan, Cory Sieburg, Kathryn J. Swoboda, Aravindhan Veerapandiyan, Beverly Assman, Silvia Bader‐Weder, Travis L. Dickendesher, Jennifer L. Hansen, Helen Lin, Ying Yan, Vamshi K. Rao

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment

    Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment od Eugenio Mercuri, Giovanni Baranello, Odile Boespflug‐Tanguy, Liesbeth De Waele, Nathalie Goemans, Janbernd Kirschner, Riccardo Masson, Elena Mazzone, Astrid Pechmann, Maria Carmela Pera, Carole Vuillerot, Silvia Bader‐Weder, Marianne Gerber, Ksenija Gorni, Janine Hoffart, Heidemarie Kletzl, Carmen Martín, Tammy McIver, R. Scalco, Wai Yin Yeung, Laurent Servais

    Izdano 2022
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: